A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01440361
Recruitment Status : Withdrawn (This study was Cancelled Before Active)
First Posted : September 26, 2011
Last Update Posted : July 28, 2014
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : April 2015
  Estimated Study Completion Date : April 2015